Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Cole G BradleyCOO2017-01-10Sell5,00035,882$29.22146.1-7.4335,882 (Direct)
Cole G BradleyCOO2016-12-06Sell5,00035,882$30.61153.05-11.6335,882 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2016-12-05Sell5,000289,594$30.02150.1-9.8959,620 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Leber LauraChief Communication Officer2016-11-21Sell7,06814,331$31.73224.27-14.7514,331 (Direct)
Shak StevenChief Scientific Officer2016-11-10Sell5,000327,207$31.71158.55-14.7327,207 (Direct)
Cole G BradleyCOO2016-11-08Sell5,00035,426$29.68148.4-8.8635,426 (Direct)
Popovits Kimberly JPresident and CEO2016-11-03Sell5,313289,594$28.88153.44-6.3459,620 (Direct)
200,851 (Held by the Popovits 2010 Trust)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2016-10-11Sell5,000327,207$30.39151.95-10.99327,207 (Direct)
Cole G BradleyCOO2016-10-10Sell8,29035,426$30.59253.59-11.5735,426 (Direct)
Vaughn James JChief Commercial Officer2016-10-06Sell3,00026,079$29.6889.04-8.8626,079 (Direct)
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.150.82327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.64-1.3135,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.2-0.7327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.0227020.11
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.35-6.335,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.22-5.8829,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.1-1.35327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.21.5435,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.854.97327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.11.6235,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.92-3.3932,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.6138-1.9934,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.01-0.5515,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$2856-3.3931,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.36.37326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.08-3.3924,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-15.846,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-14.6427,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-19.5724,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-7.5527,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-7.7712,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-7.7724,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.123.9230,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.986.7130,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.12-1.7430,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.963.0930,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.16-1.7829,658 (Direct)
Popovits Kimberly JPresident and CEO2015-04-13Sell3,000203,001$31.2893.84-13.52Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-11.1429,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-15.23Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-15.0429,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-9.41Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-13.7721,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-15.286,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-19.16Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-18.01Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-16.8221,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-22.31Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-23.4822,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-25.366,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-12.12Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.08-5.9822,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-9.29Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-10.122,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.2-1.13312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.213.76Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.771.73Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.22022,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271890.19312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.111.2312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.33.64Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.48-2.0624,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.78-0.8822,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.621.92Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.367.8123,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.753.05311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27810.1922,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.52-4.62311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.28-2.5622,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.58-2.9815,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.66-1.21311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27810.1924,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-14.15308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-9.83Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.51-3.9818,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-8.52308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-11.83Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-18.6521,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-22.546,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-21.78Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-18.9121,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-13.818,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-8.83308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-9.83Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-9.6818,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-19.8313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-21.16Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-16.8518,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-17.7821,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-14.16,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-17.98318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-18.1Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-18.421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-18.421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-19.6419,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-23.44318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-21.84Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-19.9917,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-19.9917,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-18.8413,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-19.3323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-24.19Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-24.6117,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-25.8313,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-25.19
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-26.31
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-25.696,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-26.67
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-26.75
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-27.837,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-27.27327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-25.79
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-24.56,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-21.23
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-21.417,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-22.05Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-24.917,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-24.8412,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-9.83Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.48-2.6612,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.43-5.3212,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.58-2.63
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.4-3.847,087 (Direct)
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-4.752,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.96-5.02
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.53-3.91
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.08-3.514,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.54-5.986,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5-3.3917,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.7-2.9814,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.7-2.49333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.95-2.66Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884-3.3917,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.68-2.846,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.120.82288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.70.41338,768 (Direct)
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.260.636,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.52-0.99288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.2-0.7Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.1-2.73288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884-3.3917,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.55-5.4914,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-18.23Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-23.26343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-19.9517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-19.9211,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-22.2714,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-19.88348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-14.64Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-22.7414,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-23.152,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-22.69353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-22.09Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-11.2814,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-24.656,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-21358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-22.18Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-23.57Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-24.7614,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-18.65363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-18.91Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-18.91Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-19.35Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-20.3713,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-19.97367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-16.15
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-18.126,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-20.16
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-20.98Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-19.7117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-9.71
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-10.49Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.18-6.313,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.69-4.92
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.42-4.116,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.65-3.15372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.95-2.66Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.98-3.3218,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-5.39Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-10.6713,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-10.07377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-10.04Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-10.04Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-10.07377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-12.9719,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-12.88Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-9.6513,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-10.16
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-10.16
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-10.16
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-9.26
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-9.26
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-9.26
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.19-6.92
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-6.92
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.71-6.92
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-5.09Link
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.7-3.87382,849 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.38-3.6
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.8-3.6
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.1-3.6
1,419,381 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-7.81
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-7.9
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-7.9
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.76-5.9520,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.71-5.9520,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.63.32Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.242.62
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.092.62
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.132.62
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.63.32Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.182.1914,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.02-1.676,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.12.38Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.11.62Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.71.16382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828-3.3917,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.85-1.787,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.2-1.49Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.153.92387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.8-0.88Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.48-5.397,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.63-3.81
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.72-2.21
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.16-3.81
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.314.4
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.164.28
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.784.4
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.353.76392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.98-2.38
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.66-2.38
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.53-1.1
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.19-0.66
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.48-0.66
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.8-0.7Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.520.97
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.51.697,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.744.28
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.494.28
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9410.5
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1622.516,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.824.31392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.618.48Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5521.257,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.229.99Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.222.517,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.117.51392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.810.68Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.157.097,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.157.097,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.92.276,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.05-2.03392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.2-1.131,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.7-2.497,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.6-0.26392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.914.418,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.85.291,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.123.28
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.923.28
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.683.24
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.453.327,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.61-1.06
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.06-1.1
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.3-1.1
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.755.87392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.482.1519,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.21.46Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.834.327,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.083.88Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.96.58Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.926.12Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.326.83Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.24.2Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.550.52Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2510.63Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3211.36Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7913.7Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3211.36Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.45.58Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.383.92Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.087.21Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.787.94Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.127.94Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.446.29Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.065.29Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.75.29Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9215.65Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2115.65Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3516.24Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5120.17Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0820.17Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244421.85Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.227.9Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.227.9Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8728.44Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.624.48Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6522.23Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6819.11Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.220.44Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.619.48Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514054.57Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.149.94Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.448.06Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.9527993.91Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7879.14Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.481.91Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5380.21Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1582.65Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9282.65Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.6487.07Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.1387.07Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.0788.24Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.7388.24Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.8186.29Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.386.29Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9480.45Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6180.45Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5679.5Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4282.15Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7682.15Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.580.33Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.283.89Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5885.15Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2385.15Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2883.39Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2111.16Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41107.28Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528391.17Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.0492.53Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2471.42Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6870.45Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.273.29Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.874.4Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.460.34Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.560.06Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1460.25Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538939.07Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338640.16Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4839.5Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3239.07Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7936.41Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1558.65Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7958.65Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.656.99Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7854.48Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5259.02Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9459.02Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3457.82Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2556.81Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8754.84Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.634.44Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9532.66Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8432.47Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8833.65Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7833.51Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.240.81Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3334.98Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8835.32Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5835.25Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2530.99Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.132.47Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9230.93Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179827.78Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6528.02Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6530.49Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0430.87Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1434.44Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8530.24Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7435.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2735.39Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6835.39Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9135.39Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6538.5Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010035.25Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4438.79Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8838.72Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.838.79Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8838.79Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0439.29Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1738.86Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1168.96
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1168.96
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6248.06
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8952.91
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199542.37
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9150.53
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6250.53
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8150.53
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4550.53
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.634.44
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5239
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7238.36
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.138.36
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4638.36
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8238.36
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2837.17
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.646.2
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.977.04
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.839.43
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5541.4
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.625.7
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3631.31
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3631.31
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.229.74
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8539.36
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0234.11
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1140.52
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1140.52
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.847.01
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9836.13
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9836.13
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.634.91
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.734.11
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3232.86
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.420.17
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3519.32
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4824.14
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6517.97
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0319.22
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0814.28
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460611.59
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1213.85
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125228.81
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1540.45
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20235.25
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0435.79
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7735.86
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4635.86
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0535.86
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2850.36
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522544.27
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.240.37
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6457.08
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0843.58
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.832.08
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1533.71
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2219.8
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1217.56
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1917.92
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.485.91
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8919.37
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9317.1
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4122.95
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8417.25
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4416.54
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9234.18
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8436.34
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.437.31
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2837.38
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5938.22
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3744.19
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9235.86
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9939.15
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1627.71
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018842.29
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9241.18
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2954.04
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8965.75
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8765.75
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.165.75
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0965.75
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7763.05
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6663.05
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.963.05
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6263.05
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6174.52
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0274.52
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.674.52
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8474.52
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9574.52
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9574.52
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4462.76
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.565.85
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2456.63
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4357.63
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1547.98
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8747.98
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.347.98
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2847.98
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2647.98
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.247.41
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1549.53
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8849.53
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.449.45
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0949.53
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4149.53
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1648.79
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2637.8
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1445.9
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.245.9
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7345.9
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0445.9
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0445.9
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5748.22
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5648.22
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0448.22
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6748.22
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5548.22
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4449.28
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8142.59
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8525.35
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4525.35
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1725.35
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0725.35
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.723.12
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3831.31
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8831.31
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1331.31
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2631.31
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.7292.53Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.2192.53Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.1792.53Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79125.42Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21125.42Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK